Based on our recent observations on the intrinsic link between FAK and the BRD4‐MYC axis in solid tumors, we next explored the feasibility of the FAK and BRD4 inhibitors—based co‐inhibition for MYChigh CRC tumor cell lines [26, 29]. Here, PTK2 is linked to colorectal carcinoma.